Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program
Condition(s) studied
Investigational drug(s) / intervention(s)
Cardiovascular rehabilitation program: The cardiovascular rehabilitation program consists of a 12 weeks supervised exercises therapy (either in person or in tele-care)
Study summary
The main purpose of this study is to evaluate the hemodynamic changes in the forefoot of patients with coronary, cerebrovascular or peripheral atherosclerotic disease referred a 12-week cardiovascular rehabilitation program (PREV program).
Also, this study will describe the characteristics of patients admitted to the PREV program and their evolutions in terms of favorable, unfavorable outcomes and complications and up to one year after completion of the program.
Eligibility
Primary outcome measure(s)
- Change in toe pressure measurement — Change from baseline to 12 weeks
Results will be measured in mm Hg - Change in the toe-brachial index — Change from baseline to 12 weeks
- Change in the ankle-brachial index — Change from baseline to 12 weeks
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CLSC de Lévis - Programme PREV du CISSS de Chaudière-Appalaches | Lévis | Quebec |
More Laval University trials in Canada
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06701032 on ClinicalTrials.gov ↗ ← All trials in Canada